证券代码：601065 证券简称：江盐集团 公告编号：2025-029 江西省盐业集团股份有限公司 关于召开2025年第一次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、召开会议的基本情况 （一）股东大会类型和届次 召开的日期时间：2025 年 7 月 3 日 14 点 30 分 召开地点：江西省南昌市红谷滩新区庐山南大道铜锣湾写字楼 34 楼大 会议室 （五）网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 7 月 3 日 至2025 年 7 月 3 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过 互联网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 （六）融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 2025年第一次临时股东大会 （二）股东大会召集人：董事 ...

证券代码：601065 证券简称：江盐集团 公告编号：2025-027 江西省盐业集团股份有限公司 第二届董事会第三十八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 江西省盐业集团股份有限公司（以下简称"公司")第二届董事会第三十八 次会议于 2025 年 6 月 17 日通过通讯方式召开。会议通知已于 2025 年 6 月 17 日以邮件方式向全体董事发出。本次会议由副董事长魏伟星先生召集并主持。出 席本次会议应参加董事 7 名，实际参加董事 7 名。公司监事、高级管理人员、董 事会秘书列席会议。会议的召集、召开符合《中华人民共和国公司法》《江西省 盐业集团股份有限公司章程》及《江西省盐业集团股份有限公司董事会议事规则》 的规定，会议合法有效。 二、董事会会议审议情况 （一）审议通过《关于豁免召开第二届董事会第三十八次会议通知期限的 议案》 表决结果：7 票同意，0 票反对，0 票弃权。 （二）审议通过《关于补选公司非独立董事的议案》 因胡世平先生申请辞去公司董事长、董事、战略与提名 ...

重要内容提示： 证券代码：601065 证券简称：江盐集团 公告编号：2025-026 江西省盐业集团股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 每股分配比例 A 股每股现金红利0.22元 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/20 | － | 2025/6/23 | 2025/6/23 | 差异化分红送转： 否 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 6 月 5 日的2024年年度股东会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本642,776,079股为基数，每股派发现金红利0.22 元（含税），共计派发现金红利 ...

Group 1 - Company GuoDeWei plans to repurchase shares with a total investment of between 100 million to 150 million yuan, with a maximum repurchase price of 53 yuan per share, expecting to buy back between 1.89 million to 2.83 million shares, accounting for 0.78% to 1.17% of total share capital [1] - Company Shuangliang Energy has won a bid for the Gansu Energy Chemical Qinyang 2×660MW coal power project, with a total bid amount of 237 million yuan, representing 1.82% of the company's projected revenue for 2024 [1] - Company China Pacific Insurance reported a total premium income of 227.17 billion yuan from its two subsidiaries in the first five months, with a year-on-year growth of 10.2% for its life insurance subsidiary and 0.5% for its property insurance subsidiary [1][2] Group 2 - Company LuKang Pharmaceutical has received a drug registration certificate for injectable Cefoperazone Sodium, a third-generation cephalosporin with broad-spectrum antibacterial properties [3] - Company 吉祥航空 reported a 4.97% year-on-year increase in passenger turnover in May, with a seat occupancy rate of 86.14%, up 3.70% year-on-year [4][5] - Company DuRui Pharmaceutical's subsidiary has also received a drug registration certificate for injectable Cefoperazone Sodium [6] Group 3 - Company KeLan Software announced that part of the shares held by its controlling shareholder will be auctioned, involving 5.09 million shares, accounting for 1.07% of the total share capital [7] - Company HuaCan Optoelectronics received a government subsidy of 87.84 million yuan, which is expected to positively impact the company's pre-tax profit for 2025 [8] - Company JinZhi Technology has won a bid for projects from the State Grid and China Resources New Energy, with a total bid amount of 84.41 million yuan [9] Group 4 - Company Vision China completed a capital increase for its subsidiary, raising 100 million yuan to accelerate its layout in the AI field [11] - Company Youa Co. received a profit distribution of 96.03 million yuan from its investment in Changsha Bank [13] - Company WanBangde's subsidiary obtained a patent for a deuterated compound, enhancing the chemical stability and reducing toxicity [16] Group 5 - Company DongCheng Pharmaceutical completed the enrollment of all 488 participants in the Phase III clinical trial for Fluorine-18 PSMA peptide injection, aimed at prostate cancer diagnosis [17] - Company China Merchants Expressway announced that its first phase of medium-term notes for 2024 will pay interest on July 2, 2025, with a total issuance of 2.5 billion yuan and an interest rate of 2.35% [18] - Company JinPu Titanium's subsidiary has temporarily suspended production for maintenance due to falling product prices and high production costs [20] Group 6 - Company BeiLu Pharmaceutical received a marketing authorization for Iodinated Contrast Injection in Hungary, marking another approval in the EU [22] - Company LiXing Co. obtained an overseas investment certificate for its wholly-owned subsidiary in Singapore, with a total investment of 2.16 million yuan [24] - Company LangKun Technology won a garbage collection service project with a bid amount of 21.57 million yuan [26] Group 7 - Company KeRui International plans to transfer 55% of its subsidiary Tianjin ZhiRui's equity for 41.96 million yuan [28] - Company Nanjing JuLong intends to invest 130 million yuan to build a production project for special materials with an annual output of 40,000 tons [30] - Company NanShan Intelligent plans to use up to 50 million yuan of idle funds for cash management in safe and liquid financial products [32] Group 8 - Company GuangLian Aviation completed the business change registration for its subsidiary, involving the introduction of strategic investors [34] - Company XiaoFang Pharmaceutical signed a cooperation agreement to develop a new drug for hair loss treatment [36] - Company GuiZhou SanLi plans to sign a 150 million yuan technology transfer and development contract with Guangdong Pharmaceutical University [38] Group 9 - Company ST SiLong's subsidiary received a drug registration certificate for Famotidine injection, used for treating upper gastrointestinal bleeding [52] - Company ZhongKe Information's executive plans to reduce holdings of up to 180,000 shares, accounting for 0.06% of total share capital [53] - Company KeLun Pharmaceutical's injectable Cefoperazone Sodium/Chloride Sodium injection received drug registration approval [54] Group 10 - Company LuXin Investment plans to transfer 10.06% of its stake in LuXin HuiJin for 203 million yuan, aiming to focus on its main business [56] - Company Western Gold plans to acquire 100% of Xinjiang MeiSheng for 1.655 billion yuan [58] - Company JinTou City Development intends to swap assets worth 5.862 billion yuan, changing its main business to urban centralized heating [60]

注：公司第二届董事会任期于 2023 年 8 月 6 日届满，公司于 2023 年 8 月 4 日发布《关 于董事会、监事会延期换届的提示性公告》（公告编号：2023-22），公司第二届董事 会延期换届，董事会各专门委员会和高级管理人员的任期相应顺延。 关于董事长辞职的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、董事离任的基本情况 二、离任对公司的影响 证券代码：601065 证券简称：江盐集团 公告编号：2025-025 江西省盐业集团股份有限公司 | 姓名 | 离任职务 | 离任时间 | 原定任期 | 离任原因 | 是否继续在上 市公司及其控 | 具体职务 | 是否存在 未履行完 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 到期日 | | 股子公司任职 | （如适用） | 毕的公开 承诺 | | 胡世平 | 董事长、 | 2025 年 6 | 2023年8月 | 工作变动 | 否 | 无 | 否 | | | 董事、战 ...

Core Points - The company announced the resignation of Mr. Hu Shiping from his positions as Chairman, Director, and member of the Strategy and Nomination Committee due to work changes [1] - Following his resignation, Mr. Hu will no longer hold any positions within Jiangyan Group or its subsidiaries [1] - Mr. Hu holds 459,700 shares of the company and will continue to comply with relevant laws and regulations [1]

江西省盐业集团股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券代码：601065 证券简称：江盐集团 公告编号：2025-024 本次会议是否有否决议案：无 一、会议召开和出席情况 (一)股东大会召开的时间：2025 年 6 月 5 日 (二)股东大会召开的地点：江西省南昌市红谷滩新区庐山南大道 369 号铜锣湾写 字楼 34 楼大会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 321 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 369,437,915 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 57.4753 | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由董事会召集，董事长胡世平先生主持，采取现场投票与网络 投票相结合的表决方式。表决方式符合《公司法》 ...

北京市嘉源律师事务所 关于江西省盐业集团股份有限公司 2024年年度股东大会的 法律意见书 手 名 所 OFFICES 西城区复兴门内大街158号远洋大厦4楼 中国·北京 源 : A YUAN LAW OFFICES 在本法律意见书中,本所律师仅对本次股东大会的召集、召开程序、出席会 议人员资格、召集人资格、会议表决程序、表决结果等所涉及的有关法律问题发 表意见,不对本次股东大会审议的议案内容以及该等议案所表述的事实或数据的 真实性及准确性发表意见。 本所及经办律师依据《中华人民共和国证券法》《律师事务所从事证券法律 业务管理办法》和《律师事务所证券法律业务执业规则》等规定及本法律意见书 出具日以前已经发生或者存在的事实,严格履行了法定职责,遵循了勤勉尽责和 1 北京 BEIJING·上海 SHANGHAI·深圳 SHENZHEN·香港 HONG KONG·广州 GUANGZHOU·西安 XI'AN 致:江西省盐业集团股份有限公司 北京市嘉源律师事务所 关于江西省盐业集团股份有限公司 2024年年度股东大会的法律意见书 嘉源(2025)-04-399 北京市嘉源律师事务所(以下简称"本所")接受江西省盐业集团 ...

Core Viewpoint - The company is focused on deepening reform and innovation, optimizing its industrial layout, and enhancing governance capabilities to achieve sustainable growth and value creation in the salt industry. Group 1: Company Strategy and Operations - The company aims to enhance the comprehensive development and utilization of salt resources, focusing on vertical and horizontal integration to drive profitability and create a complete supply chain for salt and related products [5][6]. - The company has increased its R&D investment to 3.8% of revenue, resulting in 30 new patents in 2024 and recognition for technological advancements in salt and chemical production [6][7]. - The company is committed to improving governance and operational compliance, receiving an "excellent" rating from the provincial state-owned assets supervision and administration commission for its board construction [7][9]. Group 2: Financial Performance - As of December 31, 2024, the company reported total assets of 566,110.95 million yuan, a decrease of 1.31% from the previous year, while total liabilities decreased by 21.96% to 121,838.85 million yuan [17][19]. - The company achieved a net profit of 460.97 million yuan in 2024, a decline of 6.88% compared to the previous year, attributed to lower product prices [19][22]. - The company proposed a cash dividend of 2.20 yuan per 10 shares, amounting to a total distribution of 141.41 million yuan, representing 30.68% of the net profit [22][23]. Group 3: Future Outlook - The company plans to focus on technological innovation and digital transformation to upgrade traditional industries and explore new growth areas in the "dual new" sectors [11][12]. - The company aims to enhance its ESG framework and market value management to align with national policies and improve its overall corporate responsibility [12][19]. - The company anticipates continued operational stability and aims to leverage its financial strength to support future growth initiatives [20][21].

江西省盐业集团股份有限公司 2024 年年度股东大会会议材料 江西省盐业集团股份有限公司 2024 年年度股东大会会议材料 股票简称：江盐集团 股票代码：601065 南 昌 二〇二五年六月 江西省盐业集团股份有限公司 2024 年年度股东大会会议资料 目 录 | 股东大会会议须知 | 3 | | | --- | --- | --- | | 2024 年年度股东大会议程 | | 4 | | 议案一：2024 | 年度董事会工作报告 | 6 | | 议案二：2024 | 年度监事会工作报告 | 10 | | 议案三：2024 | 年年度报告全文及摘要 | 13 | | 议案四：2024 | 年度财务决算报告 | 14 | | 议案五：2024 | 年度利润分配预案 | 20 | | 议案六：关于公司确认 | 2024 年度关联交易及预计 2025 年度关联交易的议案 21 | | | 议案七：关于公司及其子公司申请 | 2025 年度债务融资额度的议案 25 | | | 议案八：2025 | 年度固定资产投资计划 | 26 | | 听取《2024 | 年度独立董事述职报告》 | 27 | 2 江西省盐业集团股份 ...